Patents by Inventor Matthias Eckhardt

Matthias Eckhardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

D-xylopyranosyl-phenyl-substituted cycles, medicaments containing such compounds, their use and process for their manufacture

Publication number: 20060035841

Abstract: A D-Xylopyranosyl-phenyl-substituted cycle compound of general formula I wherein the groups R1 to R6, Z, X, Cy and R7a, R7b and R7c are defined as in claim 1, have an inhibiting effect on the sodium-dependent glucose cotransporter SGLT. The present invention also relates to pharmaceutical compositions for the treatment of metabolic disorders.

Type: Application

Filed: August 9, 2005

Publication date: February 16, 2006

Applicant: Boehringer Ingelheim International GmbH

Inventors: Matthias Eckhardt, Frank Himmelsbach, Peter Eickelmann, Leo Thomas, Edward Barsoumian
D-xylopyranosyl-phenyl-substituted cycles, medicaments containing such compounds, their use and process for their manufacture

Publication number: 20060025349

Abstract: D-Glucopyranosyl-phenyl-substituted cycles of general formula I wherein the groups R1 to R6, Z, Cy and R7a, R7b, R7c, R7d are defined as in claim 1, have an inhibiting effect on the sodium-dependent glucose cotransporter SGLT. The present invention also relates to pharmaceutical compositions for the treatment of metabolic disorders.

Type: Application

Filed: July 27, 2005

Publication date: February 2, 2006

Applicant: Boehringer Ingelheim International GmbH

Inventors: Matthias Eckhardt, Frank Himmelsbach, Peter Eickelmann, Leo Thomas, Edward Barsoumian
Methylidene-D-xylopyranosyl- and oxo-D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture

Publication number: 20060019948

Abstract: D-Xylopyranosyl-substituted phenyls of general formula I wherein the groups R1 to R5, X, Z and R7a, R7b, R7c are defined as in claim 1, have an inhibiting effect on the sodium-dependent glucose cotransporter SGLT. The present invention also relates to pharmaceutical compositions for the treatment of metabolic disorders.

Type: Application

Filed: July 15, 2005

Publication date: January 26, 2006

Applicant: Boehringer Ingelheim International GmbH

Inventors: Matthias Eckhardt, Frank Himmelsbach, Peter Eickelmann, Leo Thomas, Edward Barsoumian
D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture

Publication number: 20060009400

Abstract: A D-Xylopyranosyl-substituted phenyl compound of general formula I wherein the groups R1 to R5, X, Z and R7a, R7b, R7c are defined as in claim 1, have an inhibiting effect on the sodium-dependent glucose cotransporter SGLT. The present invention also relates to pharmaceutical compositions for the treatment of metabolic disorders.

Type: Application

Filed: June 28, 2005

Publication date: January 12, 2006

Applicant: Boehringer Ingelheim International GmbH

Inventors: Matthias Eckhardt, Frank Himmelsbach, Peter Eickelmann, Leo Thomas, Edward Barsoumian
New imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions

Publication number: 20060004074

Abstract: The present invention relates to imidazoles and triazoles of general formula wherein R1 to R4 and X are defined as in claims 1 to 8, the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).

Type: Application

Filed: June 24, 2005

Publication date: January 5, 2006

Applicant: Boehringer Ingelheim International GmbH

Inventors: Matthias Eckhardt, Frank Himmelsbach, Elke Langkopf, Leo Thomas, Mohammad Tadayyon
Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides

Publication number: 20050261352

Abstract: The invention relates to new substituted imidazoles of general formula wherein R1 to R3 and X are defined as in the claims, the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, and processes for preparing them and their use as intermediates for preparing pharmaceutical compositions or pesticides.

Type: Application

Filed: May 9, 2005

Publication date: November 24, 2005

Applicant: Boehringer Ingelheim International GmbH

Inventor: Matthias Eckhardt
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions

Publication number: 20050234108

Abstract: The present invention relates to substituted xanthines of general formula wherein R is defined as in claim 1, the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).

Type: Application

Filed: February 17, 2005

Publication date: October 20, 2005

Applicant: Boehringer Ingelheim International GmbH

Inventors: Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Mohammad Tadayyon, Leo Thomas
2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions

Publication number: 20050234235

Abstract: The present invention relates to 2-amino-imidazo[4,5-d]pyridazin-4-ones and 2-amino-imidazo[4,5-c]pyridin-4-ones of general formula wherein R1 to R4 and X are defined as in claims 1 to 6, the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).

Type: Application

Filed: April 8, 2005

Publication date: October 20, 2005

Applicant: Boehringer Ingelheim International GmbH

Inventors: Matthias Eckhardt, Frank Himmelsbach, Elke Langkopf, Norbert Hauel, Mohammad Tadayyon, Leo Thomas
Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture

Publication number: 20050209166

Abstract: Glucopyranosyl-substituted benzene derivatives of general formula I where the groups R1 to R6 as well as R7a, R7b, R7c are defined herein and the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.

Type: Application

Filed: March 15, 2005

Publication date: September 22, 2005

Applicant: Boehringer Ingelheim International GmbH

Inventors: Matthias Eckhardt, Peter Eickelmann, Frank Himmelsbach, Edward Barsoumian, Leo Thomas
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions

Publication number: 20050203095

Abstract: The invention relates to substituted imidazopyridazinediones of general formula wherein R1 and R4 are defined as in claim 1, the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).

Type: Application

Filed: March 9, 2005

Publication date: September 15, 2005

Applicant: Boehringer Ingelheim International GmbH

Inventors: Matthias Eckhardt, Frank Himmelsbach, Iris Kauffmann-Hefner, Elke Langkopf, Mohammad Tadayyon, Leo Thomas
8-[3-Amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition

Publication number: 20050187227

Abstract: The present invention relates to substituted xanthines of general formula wherein R1 and R2 are defined as in the claims, the tautomers, the stereoisomers, the mixtures thereof, and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).

Type: Application

Filed: February 22, 2005

Publication date: August 25, 2005

Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG

Inventors: Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Mohammad Tadayyon, Leo Thomas
New piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutial compositions

Publication number: 20050171093

Abstract: The present invention relates to substituted imidazo[4,5-d]pyridazin-4-ones of general formula wherein R1 to R3 and n are defined as in claims 1 to 8, the tautomers, enantiomers, diastereomers, mixtures thereof and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).

Type: Application

Filed: December 17, 2004

Publication date: August 4, 2005

Applicant: Boehringer Ingelheim International GmbH

Inventors: Matthias Eckhardt, Norbert Hauel, Frank Himmelsbach, Iris Kauffman-Hefner, Elke Langkopf, Mohammad Tadayyon, Leo Thomas
Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions

Publication number: 20050143377

Abstract: The present invention relates to bicyclic imidazole compounds of general formula wherein R1 to R3 and A are defined as in claims 1 to 8, the tautomers, the enantiomers, the stereoisomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).

Type: Application

Filed: December 21, 2004

Publication date: June 30, 2005

Applicant: Boehringer Ingelheim International GmbH

Inventors: Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Norbert Hauel, Mohammad Tadayyon, Leo Thomas
8-(piperazin-1yl)- and 8-([1,4]diazepan-1yl)-xanthines, the preparation thereof and their use as pharmaceutical composition

Publication number: 20050130985

Abstract: The present invention relates to substituted xanthines of the general formula in which R1 to R3 and n are as defined in claims 1 to 8, their tautomers, their enantiomers, their diastereomers, their mixtures, their prodrugs and their salts, which have valuable pharmacological properties, in particular an inhibitory action on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).

Type: Application

Filed: November 2, 2004

Publication date: June 16, 2005

Applicant: Boehringer Ingelheim International GmbH

Inventors: Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Mohammad Tadayyon, Leo Thomas
New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions

Publication number: 20050026921

Abstract: The present invention relates to substituted imidazo-pyridinones and imidazo-pyridazinones of general formula wherein Y and R1 to R4 are defined as in claim 1, the tautomers, enantiomers, diastereomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).

Type: Application

Filed: June 10, 2004

Publication date: February 3, 2005

Applicant: Boehringer ingelheim international GmbH

Inventors: Matthias Eckhardt, Norbert Hauel, Elke Langkopf, Frank Himmelsbach, Iris Kauffmann-Hefner, Mohammad Tadayyon, Michael Mark
New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions

Publication number: 20050020574

Abstract: The present invention relates to substituted imidazo-pyridinones and imidazo-pyridazinones of general formula wherein R1 to R4 are defined as in claim 1, the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibitory effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).

Type: Application

Filed: December 2, 2003

Publication date: January 27, 2005

Applicant: Boehringer Ingelheim Pharma GmbH Co. KG

Inventors: Norbert Hauel, Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Roland Maier, Michael Mark, Mohammad Tadayyon, Iris Kauffmann-Hefner
Xanthine derivatives, their preparation and their use in pharmaceutical compositions

Publication number: 20040166125

Abstract: Compounds of formula (I) 1

Type: Application

Filed: August 7, 2003

Publication date: August 26, 2004

Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG

Inventors: Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Michael Mark, Roland Maier, Ralf R. H. Lotz
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

Publication number: 20040138214

Abstract: Disclosed are substituted xanthines of general formula 1

Type: Application

Filed: October 28, 2003

Publication date: July 15, 2004

Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG

Inventors: Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Roland Maier, Michael Mark, Mohammad Tadayyon, Ralf R. H. Lotz
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

Publication number: 20040138215

Abstract: The present invention relates to substituted xanthines of general formula 1

Type: Application

Filed: November 18, 2003

Publication date: July 15, 2004

Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG

Inventors: Matthias Eckhardt, Frank Himmelsbach, Elke Langkopf, Roland Maier, Michael Mark, Mohammad Tadayyon
New purine derivatives, the preparation thereof and their use as pharmaceutical compositions

Publication number: 20040122228

Abstract: The invention relates to new purine derivatives of general formula 1

Type: Application

Filed: August 4, 2003

Publication date: June 24, 2004

Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG

Inventors: Roland Maier, Frank Himmelsbach, Matthias Eckhardt, Elke Langkopf, Michael Mark, Ralf R. H. Lotz

prev … 8 9 10 11 12 13 next